Abstract
A pathologic report for radical orchiectomy specimens with tumors should include the following information: serum tumor markers [alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), lactic acid dehydrogenase (LDH)], specimen laterality, tumor focality, tumor size, macroscopic extent of tumor, histologic type of tumor, margin status, microscopic tumor extension, lymph-vascular invasion, pTNM including S status, and additional pathologic findings [i.e., germ cell neoplasia in situ (GCNIS), atrophy]. As far as tumor sampling is concerned, 1 cm2 sections for every centimeter of maximum tumor diameter should be taken, including normal macroscopic parenchyma (if present), albuginea, and epididymis, the latter two with selection of suspected areas. The most important stain for testicular cancer histologic diagnosis is hematoxylin-eosin (H-E); immunohistochemistry is particularly useful in histologic typing of tumors with extensive necrosis, poor fixation, or ambiguous morphology as well as in metastatic tumors. In the microscopic examination of tumor specimens, the presence or absence of peritumoral venous and/or lymphatic vascular invasion should be carefully investigated and reported. It should be stressed that the diagnosis of choriocarcinoma requires the identification of mononucleated cytotrophoblastic cells. In stage 1 seminomas, the presence or absence of invasion of the rete testis should be reported. With regard to microscopic evaluation of tumors with mixed histology, the individual components should be specified, and their amount should be estimated as a percentage.
In experienced hands, guided fine needle cytology and/or core biopsy can be valuable tools for the morphological diagnosis of retroperitoneal and mediastinal manifestations of malignant germ cell tumors.
A pathologic report for retroperitoneal lymphadenectomy specimens should include the following data: pre-lymphadenectomy treatment, serum tumor markers, specimen site(s), number of nodal groups present, size of largest metastatic deposit in lymph node, histologic viability of tumor, histologic type of metastatic tumor, pN status, nonregional lymph node metastasis (M1a).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmed H, Arya M, Mushtaq I et al (2010) Testicular and paratesticular tumours in pre-pubertal population. Lancet Oncol 11:476–483
Al-Agha OM, Axiotis CA (2007) An indepth look at Leydig cell tumor of the testis. Arch Pathol Lab Med 131:311–317
Alanee S, Shukla AR, Metcalf PD et al (2009) Paediatric testicular cancer: an updated review of incidence and conditional survival from the surveillance, epidemiology and end results database. Br J Urol Int 104:1280–1283
Albers P (2016) Testicular cancer. In: European Association of Urology Guidelines. European Association of Urology. Available via https://uroweb.org/guideline/testicular-cancer. Accessed 24 Nov 2016
Amin W, Parwani A (2009) Adenomatoid Tumor of Testis. Clin Med Pathol 2:17–22
Amin MB (ed) (2010) Diagnostic Pathology. Genitourinary. AMIRSYS, Salt Lake City
Arndt CA, Stoner JA, Hawkins DS et al (2009) Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803. J Clin Oncol 27(31):5182–5188
Bahrami A, Ro JY, Ayala AG (2007) An Overview of Testicular Germ Cell Tumors. Arch Pathol Lab Med 131(8):1267–1280
Beck SD, Foster RS, Bihrle R et al (2007) Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor? Cancer 110:1235–1240
Berkowitz GS, Lapinski RE, Dolgin SE et al (1993) Prevalence and natural history of cryptorchidism. Pediatrics 92:44
Boden G, Gibb R (1951) Radiotherapy and testicular neoplasms. Lancet 2(6696):1195–1197
Bostwick DG, Chen L (eds) (2014) Urologic Surgical Pathology. MOSBY Elsevier, Amsterdam
Carmignani L, Salvioni R, Gadda F et al (2006) Long-term follow-up and clinical characteristics of testicular Leydig cell tumor: experience with 24 cases. J Urol 176:2040–2043
Cerilli LA, Kuang W, Rogers D (2010) A practical approach to testicular biopsy interpretation for male infertility. Arch Pathol Lab Med 134:1197–1204
Cortes D, Thorup JM, Visfeldt J (2001) Cryptorchidism: aspect of fertility and neoplasms. A study including data of 1335 consecutive boys who underwent testicular biopsy simultaneously with surgery for cryptorchidism. Horm Res 55:21–25
Hadziselimovic F, Herzog B (2001) The importance of both and early orchidopexy and germ cell maturation for fertility. Lancet 358:1156–1157
International Germ Cell Cancer Collaborative Group Consensus Classification (1997) A prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 15(2):594–603
Khan O, Protheroe A (2007) Testis Cancer. Postgrad Med J 83:624–632
Moch H, Humphrey PA, Ulbright TM, Reuter VE (eds) (2016) WHO Classification of Tumours of the urinary System and Male Genital Organs. IARC, Lyon
NCCN Guidelines Version 2.2017 (2016) In: National Comprehensive Cancer Network, 1/11/2016. Available via https://www.nccn.org/professionals/testicularcancer. Accessed 18 Nov 2016
Nielsen OS, Munro AJ, Duncan W et al (1990) Is placental alkaline phosphatase (PLAP) a useful marker for seminoma? Eur J Cancer 26(10):1049–1054
Oldenburg J, Alfsen GC, Lien HH et al (2003) Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. J Clin Oncol 21:3310–3317
Oldenburg J, Fosså SD, Nuver J et al (2013) Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(Suppl 6):vi125–vi132
Pohl H, Shukla A, Metcalf P et al (2004) Pre-pubertal testis tumour: actual prevalence rate of histological types. J Urol 172:2370–2372
Presti JC (2013) Genital Tumors. In: McAninch J, Lue T (eds) Smith and Tanagho’s General Urology, 18th edn. McGraw-Hill, New York, pp 380–392
Rabbani F, Goldenberg SL, Gleave ME et al (1998) Retroperitoneal lymphadenectomy for post-chemotherapy residual masses: is a modified dissection and resection of residual masses sufficient? Br J Urol 81:295–300
Saleh R, Mahfouz EZ, Agarwal A, Farouk H (2010) Ηistopathologic patterns of testicular biopsies in infertile azoospermic men with varicocele. Fertile Steril 94:2482–2485
SEER Cancer Statistics FactSheets (2016) Testis Cancer. National Cancer Institute. Bethesda, MD. Available via http://seer.cancer.gov/statfacts/html/testis.html
Siegel RL, Miller KD, Jemal A (2016) Cancer statistics. CA Cancer J Clin 66:7–30
Silverberg E (1982) Cancer in young adults (ages 15–34). CA Cancer J Clin 32:32–42
Stephenson A, Gilligan T (2012) Neoplasms of the testis. In: Kavoussi L, Novick A, Partin A, Peters C (eds) Campbell-Walsh Urology, 10th edn. Saunders, Philadelphia, pp 837–867
Taskinen S, Fagerholm R, Aronniemi J et al (2008) Testicular tumors in children and adolescents. J Pediatr Urol 4:134–137
Taylor JG, Cheuk AT, Tsang PS et al (2009) Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models. J Clin Invest 119(11):3395–3407
Trussel JC, Lee PA (2004) The relationship of cryptorchidism to fertility. Curr Urol Rep 5:142–145
Williams SB, Han M, Jones R, Andrawis R (2004) Adenomatoid tumor of the testes. Urology 63(4):779–781
Wood DP Jr, Herr HW, Heller G et al (1992) Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors. J Urol 148:1812–1815. discussion 1815-1816
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Charitopoulos, K. et al. (2018). Neoplastic Testicular Pathology. In: Lazaris, A. (eds) Clinical Genitourinary Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-72194-1_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-72194-1_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-72193-4
Online ISBN: 978-3-319-72194-1
eBook Packages: MedicineMedicine (R0)